265
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Burden and Characteristics of Severe Chronic Hypoxemia in a Real-World Cohort of Subjects with COPD

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 1275-1284 | Published online: 10 May 2021

References

  • Albert RK, Au DH, Blackford AL, et al.; Long-Term Oxygen Treatment Trial Research Group. A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med. 2016;375:1617–1627.
  • Bressler RB, Awe RJ. Oxygen therapy in chronic obstructive lung disease. Ann Intern Med. 1981;94:410. doi:10.7326/0003-4819-94-3-410_1
  • Sundh J, Ekström M. Risk factors for developing hypoxic respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2095–2100. doi:10.2147/COPD.S140299
  • Wells JM, Estepar RS, McDonald MN, et al. Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study. BMC Pulm Med. 2016;16:169. doi:10.1186/s12890-016-0331-0
  • Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf. Accessed April 20, 2021.
  • Lim S, MacRae KD, Seed WA, Roberts CM. The value of forced expiratory volume in 1 s in screening subjects with stable COPD for PaO2 < 7.3 kPa qualifying for long-term oxygen therapy. Respir Med. 1998;92(9):1122–1126. doi:10.1016/s0954-6111(98)90405-x
  • Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial, Ann Intern Med. 1980;93(3):391–398. PMID: 6776858. doi:10.7326/0003-4819-93-3-391
  • Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981;1(8222):681–686. PMID: 6110912.
  • Burgel PR, Paillasseur JL, Janssens W, et al. A simple algorithm for the identification of clinical COPD phenotypes. Eur Respir J. 2017;50:1701034. doi:10.1183/13993003.01034-2017
  • Burgel PR, Paillasseur JL, Caillaud D, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J. 2010;36:531–539. doi:10.1183/09031936.00175109
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.00034805
  • Chaouat A, Weitzenblum E, Kessler R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999;14:1002–1008. doi:10.1183/09031936.99.14510029
  • Górecka D, Gorzelak K, Sliwiński P, Tobiasz M, Zieliński J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax. 1997;52:674–679. doi:10.1136/thx.52.8.674
  • Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80:112–119. doi:10.1159/000281880
  • Raff H, Bruder ED, Jankowski BM. The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine. 1999;11:37–39. doi:10.1385/ENDO:11:1:37
  • Cheng N, Cai W, Jiang M, Wu S. Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res. 1997;41:852–856. doi:10.1203/00006450-199706000-00009
  • Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med. 2010;27:977–987. doi:10.1111/j.1464-5491.2010.03073.x
  • Rogliani P, Calzetta L, Segreti A, Barrile A, Cazzola M. Diabetes mellitus among outpatients with COPD attending a university hospital. Acta Diabetol. 2014;51:933–940. doi:10.1007/s00592-014-0584-0
  • Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531–1536. doi:10.1378/chest.127.5.1531
  • Olsson KM, Fuge J, Meyer K, Welte T, Hoeper MM. More on idiopathic pulmonary arterial hypertension with a low diffusing capacity. EurRespirJ. 2017;50:1700354.
  • Kovacs G, Agusti A, Barberà JA, et al. Pulmonary vascular involvement in chronic obstructive pulmonary disease. Is there a pulmonary vascular phenotype? Am J Respir Crit Care Med. 2018;198:1000–1011. doi:10.1164/rccm.201801-0095PP